SCHEMBL19725554

SCHEMBL19725554

CC(C)(C)OC(=O)N1CCC(CN(C(=O)OC(C)(C)C)C2CC2c2ccc3c(c2)CCN3)CC1

nearest known ligand 0.40

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 8/20 0.40
MAPK1 P28482 1/20 0.39
ACHE P22303 5/20 0.39
DDB1 Q16531 1/20 0.38
CRBN Q96SW2 1/20 0.38
TACR3 P29371 1/20 0.38
ALDH1A1 P00352 1/20 0.37
CYP2C9 P11712 1/20 0.37
ALOX15 P16050 1/20 0.37
CYP2C19 P33261 1/20 0.37
KDM4E B2RXH2 1/20 0.37
PKM P14618 1/20 0.37
EZH2 Q15910 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21155772 1.00 GPR119 (0.40) GPR119MAPK1ACHEDDB1CRBN
SCHEMBL21114613 1.00 GPR119 (0.40) GPR119MAPK1ACHEDDB1CRBN
SCHEMBL28767601 0.93 ACHE (0.39) ACHEALDH1A1CYP2C9ALOX15CYP2C19
SCHEMBL19725556 0.89 KDM1A (0.39) ACHEEZH2
SCHEMBL21114708 0.85 ACHE (0.35) ACHEALDH1A1CYP2C9ALOX15CYP2C19
SCHEMBL16394573 0.82 GPR119 (0.52) GPR119DDB1CRBNKDM4EPKM
SCHEMBL16394574 0.82 GPR119 (0.52) GPR119DDB1CRBNKDM4EPKM
SCHEMBL16394326 0.81 FPR2 (0.44) GPR119KDM4EPKM
SCHEMBL16394325 0.81 FPR2 (0.44) GPR119KDM4EPKM
SCHEMBL16407913 0.81 FPR2 (0.44) GPR119KDM4EPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11873292-B2 Trans-indoline cyclopropylamine chemical compound, and method for preparation, pharmaceutical composition, and use thereof SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2024-01-16 US disclosed
US-11873292-B2 Trans-indoline cyclopropylamine chemical compound, and method for preparation, pharmaceutical composition, and use thereof SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2024-01-16 US disclosed
US-20190210998-A1 TRANS-INDOLINE CYCLOPROPYLAMINE CHEMICAL COMPOUND, AND METHOD FOR PREPARATION, PHARMACEUTICAL COMPOSITION, AND USE THEREOF SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2019-07-11 US disclosed
WO-2017215464-A1 TRANS-INDOLINE CYCLOPROPYLAMINE CHEMICAL COMPOUND, AND METHOD FOR PREPARATION, PHARMACEUTICAL COMPOSITION, AND USE THEREOF 中国科学院上海药物研究所 2017-12-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190210998-A1 TRANS-INDOLINE CYCLOPROPYLAMINE CHEMICAL COMPOUND, AND METHOD FOR PREPARATION, PHARMACEUTICAL COMPOSITION, AND USE THEREOF INMT, IDO1, TPH1 GPR119 1424/4885MAPK1 1450/4885ACHE 794/4885
US-11873292-B2 Trans-indoline cyclopropylamine chemical compound, and method for preparation, pharmaceutical composition, and use thereof INMT, IDO1, TPH1 GPR119 1424/4885MAPK1 1450/4885ACHE 794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.